Nova Eye Medical Limited (ELXMF)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Victor Previn B.E., B.Eng | Founder & Executive Chairman | 153.68k | -- | 1958 |
Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. | MD & Executive Director | 163.87k | -- | 1962 |
Liam Cook | Chief Financial Officer | -- | -- | -- |
Mr. Keith Byrne | Vice President of Global Operations | -- | -- | -- |
Mark Flynn | Investor Relations | -- | -- | -- |
Ms. Kate Hunt | Head of Marketing | -- | -- | -- |
Dr. David Lubeck M.D. | Chief Medical Officer | -- | -- | -- |
Mr. Joaquin V. Wolff | President of Ellex iTrack | -- | -- | 1958 |
Ms. Kimberley Menzies | Group Financial Controller & Global Finance Manager | -- | -- | -- |
Mr. Simon Jeremy Newton Gray BEc, C.A., CA | Company Secretary | -- | -- | 1959 |
Nova Eye Medical Limited
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Corporate Governance
Recent Events
- Jul 21, 2020Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available